ANGLE (ANPCF) Debt-to-Asset : 0.11 (As of Jun. 2023)

View and export this data going back to 2014. Start your Free Trial

What is ANGLE Debt-to-Asset?

ANGLE's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.77 Mil. ANGLE's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $5.00 Mil. ANGLE's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2023 was $50.71 Mil. ANGLE's debt to asset for the quarter that ended in Jun. 2023 was 0.11.

ANGLE Debt-to-Asset Historical Data

The historical data trend for ANGLE's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANGLE Debt-to-Asset Chart

ANGLE Annual Data

Trend

Apr13

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Debt-to-Asset

Get a 7-Day Free Trial

0.04

0.05

0.10

ANGLE Semi-Annual Data
	Oct13	Apr14	Oct14	Apr15	Oct15	Apr16	Oct16	Apr17	Oct17	Apr18	Oct18	Apr19	Oct19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Debt-to-Asset	Get a 7-Day Free Trial															0.08	0.05	0.13	0.10	0.11

Competitive Comparison of ANGLE's Debt-to-Asset

For the Diagnostics & Research subindustry, ANGLE's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ANGLE's Debt-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ANGLE's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where ANGLE's Debt-to-Asset falls into.

ANGLE Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

ANGLE's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.806	+	5.285)	/	60.741
	=	0.10

ANGLE's Debt-to-Asset for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.774	+	5.001)	/	50.712
	=	0.11

ANGLE (OTCPK:ANPCF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

ANGLE Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of ANGLE's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

ANGLE (ANPCF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ANGLE PLC (OTCPK:ANPCF) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

ANPCY:USA AGL:UK DWV:Germany

Address

10 Nugent Road, The Surrey Research Park, Surrey, Guildford, GBR, GU2 7AF

Website

https://www.angleplc.com

ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which majority of its revenue is generated from Europe.

ANGLE (ANPCF) Headlines

From GuruFocus

Angle PLC Announces Parsortix-Harvested CTCs Uncover Novel Biomarker

By ACCESSWIRE ACCESSWIRE • 02-18-2021

Angle PLC Announces Holding(s) in Company - (1)

By ACCESSWIRE ACCESSWIRE • 07-08-2020

Angle PLC Announces Harvesting CTCs from Brain Metastasis Patients

By ACCESSWIRE ACCESSWIRE • 07-09-2021

Angle PLC Announces Exercise of Options and Total Voting Rights

By ACCESSWIRE ACCESSWIRE • 04-30-2021

Angle PLC Announces AACR 2019

By ACCESSWIRE AccessWire • 04-12-2019

Angle PLC Announces Holding(s) in Company - (2)

By ACCESSWIRE ACCESSWIRE • 07-08-2020